Keros Therapeutics, Inc. (KROS) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	S-1
Assets
Cash and equivalents	230.0	265.9	7.0	23.3
Accounts receivable, net	18.0
Other current assets	3.4	1.9	1.9	2.3
Total current assets	251.4	267.7	8.9	25.5
Property, plant, and equipment, net	1.3	0.7	0.7	0.6
Other fixed assets	0.1
Total assets	255.3	269.4	11.0	27.4

Accounts payable	3.6	2.1	2.1	0.5
Accrued expenses	7.3	4.6	2.0	0.8
Short-term debt	0.0	0.0	0.0	0.0
Other current liabilities	0.9	0.4	0.4	10.2
Total current liabilities	11.8	7.2	4.5	11.5
Other liabilities	0.2	0.5	6.0	3.2
Total liabilities	12.1	7.7	10.5	14.7

Shareholders' equity [+]	243.2	261.7	0.5	12.8
Paid-in capital	366.9	326.7	0.2	0.1
Retained earnings	-123.8	-65.0	-19.7	-7.3
Tangible shareholders' equity	243.2	261.7	0.5	12.8